US OptionsDetailed Quotes
VKTX241129P53000
- 0.22
- -0.98-81.67%
15min DelayClose Nov 27 16:00 ET
1.16High0.20Low
0.70Open1.20Pre Close61 Volume290 Open Interest53.00Strike Price3.10KTurnover61.50%IV3.17%PremiumNov 29, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.22Extrinsic Value100Contract SizeAmericanOptions Type-0.1696Delta0.1547Gamma363.40Leverage Ratio-0.2376Theta-0.0002Rho-61.63Eff Leverage0.0067Vega
Viking Therapeutics Stock Discussion
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...
🚀🚀🚀🚀 now all engines firing
lets gooooooo
No comment yet